Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
about
Case report: PET/CT, a cautionary taleThoracic and abdominal organ uptake of 2-deoxy-2-[18F]fluoro-D-glucose (18FDG) with positron emission tomography in the normal dog.Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in childrenPre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.Ability of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancerPhysiological uptake in FDG PET simulating disease.The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma.Background Intestinal 18F-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients.Background Colonic 18F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma.Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CTSurgical management of esophagogastric junction tumors.False Positive 18F-FDG Uptake in Mediastinal Lymph Nodes Detected with Positron Emission Tomography in Breast Cancer: A Case Report.Current role of radionuclide imaging in differentiated thyroid cancer.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.PET/CT in radiation oncology.Abnormal 18F-FDG Uptake Detected with Positron Emission Tomography in a Patient with Breast Cancer: A Case of Sarcoidosis and Review of the Literature.Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations.Microfluidics for positron emission tomography probe development.Metal artifact reduction strategies for improved attenuation correction in hybrid PET/CT imaging.Techniques for respiration-induced artifacts reductions in thoracic PET/CT.When should FDG-PET be used in the modern management of lymphoma?Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in response monitoring of extra-pulmonary tuberculosis.Physiologic variants, benign processes, and artifacts from 106 canine and feline FDG-PET/computed tomography scans.Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-Dimensional Cryo-Imaging After Intravenous Infusion in a Rat Lung Injury Model.Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.Intense focal Fluoro-deoxyglucose uptake in the lungs with no corresponding computed tomography abnormality.A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging.Is There a Role of Double Reporting and CT Pelvis for Lung Cancer Staging?Respiratory-induced errors in tumor quantification and delineation in CT attenuation-corrected PET images: effects of tumor size, tumor location, and respiratory trace: a simulation study using the 4D XCAT phantom.Unilateral Muscle Artifacts due to Non-compliance During Uptake Phase of 18F-FDG PET/CT in an Oncologic Patient.Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases.Altered biodistribution of FDG in patients with type-2 diabetes mellitus.PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.
P2860
Q33293417-7C55344B-D042-4C54-9693-1429E8CB096CQ33328879-80F6962D-6CC0-40FE-B17F-CDDF41EA359BQ33917066-7BB1D85F-F62F-4CD8-A14C-2AFA6EF1ADF3Q34011842-8E870AF3-951C-4D6D-9B2C-5969E641ABEDQ34223171-FE5F5A54-3658-448F-ADA0-20879B8B3442Q34991964-86DD7946-C5EC-4ACD-AA70-D186F8E2C9F7Q35687578-1AE546B8-8D0D-46D4-9176-9A87D15E3B0DQ35828985-5D84C899-3102-430B-89E8-8070B26C85B7Q36100290-53C9C41D-069D-4BA9-B9C8-01F9F7C2A142Q36150877-246A4A0E-76BF-4666-97BC-ADC086FD1351Q36640053-E9AFFDC0-D868-44F9-93CD-03683703FE4BQ36702891-A816A3A4-CBB7-46D0-9E00-D081BAB97E7DQ36915594-3AC945E5-48DB-49E5-87BF-D28886EFBB58Q37240835-00962D7A-47DA-4C13-8A33-88204B690394Q37345402-680D83AD-CFA1-45B9-B26C-CB3CDDCA68EEQ37370854-0A921EE4-C9CC-4461-92A9-626C7627EAFEQ37477867-68793D67-0B68-47D2-9847-75B98A66B629Q37708042-75CE36C7-E530-48EB-8EEB-9E065DBA86C2Q37774061-B01E3B20-2815-4EAE-9F4B-4BD6D2116014Q38023479-9650977E-D995-46A6-A720-81E2B7924CE6Q38068870-DC39D1BF-4D9D-4C78-AFCF-5863D48B1F40Q38153086-5C602B30-51AD-4AC1-93D9-8B6F13BA6C14Q38304450-EC323E88-62DC-4C3D-B078-0B253A05FA0EQ38393170-0B377412-6C6B-41A9-86D8-4D5BAAE9C021Q38837608-C433D777-30F4-438C-83A6-21B2C0AA2CFAQ39456555-E1D5BCBC-6593-438A-A3CE-361FD1FC3E96Q40408412-C1CCBCC9-18BE-42FF-9D25-E1F0C52E14E3Q41760836-2D3C9571-04E8-480F-9399-08EC01533586Q42039357-DB23AFE4-1A42-4BF2-9E24-48CF3ACED515Q46069673-5D21A423-2C24-4114-9CC2-8396D2918AC0Q47228295-07CED608-84BA-4BE3-8889-5976389F31E8Q49348931-98261E81-D68D-48D0-873E-2FF3E0D4FD6BQ51334362-54A026D7-7FD9-4005-9506-0B4FE48878B1Q51749246-47E11425-2850-46A8-8041-40832950FB8FQ53074102-F8422129-D0D7-4F75-8EEB-85BE76F575A8Q53251672-7A9E976F-C204-4810-B0BC-E8B57ACD2A9B
P2860
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@ast
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@en
type
label
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@ast
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@en
prefLabel
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@ast
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
@en
P1476
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
@en
P2093
Eva A Wegner
Ignac Fogelman
P304
P356
10.1053/J.SEMNUCLMED.2003.12.003
P50
P577
2004-04-01T00:00:00Z